Rispevon 1 mg, 2 mg, 3 mg, 4 mg FC tablet
PDF Leaflet Revision Date: 8 February 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of schizophrenia and related psychoses, behavioral disturbances in dementia, and disruptive behavior disorders in children.
Dosage (summary)
Adults: Start at 2 mg/day, increase to 4 mg/day on day 2; maintain 4-8 mg/day. Elderly: Start at 0.5 mg twice daily.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding; may cause withdrawal symptoms in neonates.
Key Drug Interactions
- Caution with furosemide
- May antagonize levodopa
- Increased risk of QT prolongation with certain drugs
Contraindications
- Hypersensitivity to risperidone
- Pregnancy
- Lactation
- Parkinsonu2019s disease
- Children under 5 years
Common side effects
- Weight gain
- Hyperprolactinaemia
- Dizziness
- Sedation
- Extrapyramidal symptoms
Counselling Points
- Monitor for weight gain
- Avoid driving until effects are known
- Report any signs of hyperglycemia
Serious warnings
- Neuroleptic Malignant Syndrome
- Tardive dyskinesia
- Intraoperative Floppy Iris Syndrome
Important Disclaimer
The Rispevon 1 mg, 2 mg, 3 mg, 4 mg FC tablet professional information leaflet below is the property of Trinity Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
